Brief: Sangui Biotech International - H1 Revenues From Royalty Income At USD 30,572
10/02/2021 10:14
Feb 10 (Reuters) - SANGUI BIOTECH INTERNATIONAL INC
SGBI.BE :
* H1 REVENUES FROM ROYALTY INCOME OF USD 30,572
* OPERATING EXPENSES INCREASED USD 8,890 OR 9% TO USD
113,286
DURING FIRST HALF YEAR
* LOSS OF FIRST HALF YEAR INCREASED BY USD 52,059 TO USD
151,185
Source text for Eikon: ID:nEQbm8bDba
Further company coverage: SGBI.BE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))